Mergers & Acquisitions - Actavis

Filter

Current filters:

Actavis

Popular Filters

Forest appeases shareholders over Actavis deal

30-05-2014

US drugmaker Forest Laboratories has reached a settlement with shareholders over its deal with generics…

ActavisBusinessBusiness FinanceEnvironmentForest LaboratoriesMajorMergers & AcquisitionsNew York Stock ExchangePharmaceuticalUSA

FTC imposes conditions on Akorn’s proposed buy of Hi-Tech Pharmacal

15-04-2014

In order to consummate the proposed $640 million acquisition of Hi-Tech Pharmacal by fellow USA-based…

ActavisAkornGenericsHi-Tech PharmacalMergers & AcquisitionsNorth AmericaUSA

Fitch affirms Actavis at “BBB-” on Forest Labs acquisition; outlook Stable

20-02-2014

Fitch Ratings has affirmed the ratings of generic drugs major Actavis and subsidiaries at “BBB-”…

ActavisFinancialForest LaboratoriesMergers & AcquisitionsPharmaceutical

Actavis confirms plan to acquire Forest Labs for about $25 billion

Actavis confirms plan to acquire Forest Labs for about $25 billion

18-02-2014

After a morning of speculation and rumors, generics drug major Actavis today confirmed that it has reached…

ActavisForest LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

Actavis to shed another business, its Actavis Foshan unit in China

Actavis to shed another business, its Actavis Foshan unit in China

26-01-2014

US generics major Actavis revealed a second divestiture this month, saying it has signed and completed…

ActavisAsia-PacificChinaGenericsMergers & AcquisitionsZhejiang Chiral

Actavis to divest certain European operations to Aurobindo

Actavis to divest certain European operations to Aurobindo

18-01-2014

US generics major Actavis plans to enter into an agreement with India’s Aurobindo Pharma for the latter…

ActavisAurobindo PharmaEuropeGenericsMergers & Acquisitions

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

12-12-2013

Following a public comment period, the US Federal Trade Commission has approved a final order settling…

ActavisGenericsMergers & AcquisitionsNorth AmericaRegulationReproductiveWarner Chilcott

Actavis sells 51% stake in Russian subsidiary

Actavis sells 51% stake in Russian subsidiary

10-12-2013

Leading global generics drugmaker Actavis says that it sold its 51% stake in the Russian drug company…

ActavisEastern EuropeFarmekoGenericsMergers & AcquisitionsRussiaZio-Zdorovye

Generics briefs: Actavis/Warner Chilcott M&A delay; Canasa patent challenge

11-07-2013

US generics major Actavis (NYSE: ACT) and Ireland-based Warner Chilcott (Nasdaq: WCRX) have each received…

ActavisAptalis PharmaCanasaGenericsLegalMergers & AcquisitionsMylan LaboratoriesNorth AmericaPatentsWarner Chilcott

Actavis confirms plan to acquire Warner Chilcott, in $8.5 billion deal

20-05-2013

US generics major Actavis (NYSE: ACT) revealed today (May 20) that it has entered into a definitive agreement…

ActavisGenericsMergers & AcquisitionsPharmaceuticalWarner ChilcottWomen's Health

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram

13-05-2013

US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

Actavis in OxyContin patent settlement; Valeant takeover bid "on hold"?

29-04-2013

US generic major Actavis (NYSE: ACT) has entered into an agreement with privately-held Purdue Pharma…

ActavisGenericsMergers & AcquisitionsNeurologicalNorth AmericaOxyContinPatentsPurdue PharmaValeant Pharmaceuticals

US FTC puts divestment conditions on Watson's acquisition of Actavis

16-10-2012

The USA's Federal Trade Commission will require Watson Pharmaceuticals (NYSE: WPI) and fellow generic…

ActavisGenericsLegalMergers & AcquisitionsNorth AmericaNovartisPar PharmaceuticalsSandozWatson Pharmaceuticals

Fitch puts Watson on rating watch Negative on planned acquisition of Actavis

26-04-2012

US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has seen its rating downgraded by Fitch Ratings,…

ActavisFinancialGenericsMergers & AcquisitionsNorth AmericaWatson Pharmaceuticals

Watson Pharma confirms buy of generic group Actavis for 4.25 billion euros

26-04-2012

As has been widely rumoured over this week, Watson Pharmaceuticals (NYSE: WPI) has confirmed a definitive…

ActavisGenericsMergers & AcquisitionsWatson Pharmaceuticals

Actavis reportedly to be acquired by Watson; debuts generic Zomig

22-03-2012

Icelandic generic drugmaker Actavis is said to be in talks to be acquired by US peer Watson Pharmaceuticals…

ActavisAstraZenecaEuropeGenericsMarkets & MarketingMergers & AcquisitionsNeurologicalPatentsWatson PharmaceuticalsZolmitriptanZomig

New Actavis/Bioton alliance aims to shake up diabetes market

31-01-2012

Icelandic generics drugmaker Actavis and Poland’s Bioton (WSE: BIO) have formed a joint venture…

ActavisBiotonDiabetesGenericsMarkets & MarketingMergers & AcquisitionsPharmaceutical

Actavis acquires Dutch company PharmaPack

04-12-2011

Iceland-headquartered generic drugmaker Actavis says it has acquired 100% of the shares in PharmaPack…

ActavisGenericsMergers & AcquisitionsPharmaPack

Back to top